data anonymisation Search Results


anonymised data  (Employee State Insurance Corporation)
90
Employee State Insurance Corporation anonymised data
Anonymised Data, supplied by Employee State Insurance Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised data/product/Employee State Insurance Corporation
Average 90 stars, based on 1 article reviews
anonymised data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
data anonymisation  (SmartSurvey Ltd)
90
SmartSurvey Ltd data anonymisation
Data Anonymisation, supplied by SmartSurvey Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/data anonymisation/product/SmartSurvey Ltd
Average 90 stars, based on 1 article reviews
data anonymisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised data  (SurveyEngine GmbH)
90
SurveyEngine GmbH anonymised data
Anonymised Data, supplied by SurveyEngine GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised data/product/SurveyEngine GmbH
Average 90 stars, based on 1 article reviews
anonymised data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised data therapyedge-hivtm  (TherapyEdge Inc)
90
TherapyEdge Inc anonymised data therapyedge-hivtm
Anonymised Data Therapyedge Hivtm, supplied by TherapyEdge Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised data therapyedge-hivtm/product/TherapyEdge Inc
Average 90 stars, based on 1 article reviews
anonymised data therapyedge-hivtm - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised data from a yougov survey  (YouGov plc)
90
YouGov plc anonymised data from a yougov survey
Anonymised Data From A Yougov Survey, supplied by YouGov plc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised data from a yougov survey/product/YouGov plc
Average 90 stars, based on 1 article reviews
anonymised data from a yougov survey - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised patient level data  (LEO Pharma)
90
LEO Pharma anonymised patient level data
Anonymised Patient Level Data, supplied by LEO Pharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised patient level data/product/LEO Pharma
Average 90 stars, based on 1 article reviews
anonymised patient level data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
data anonymisation  (Privacy Analytics Inc)
90
Privacy Analytics Inc data anonymisation
Data Anonymisation, supplied by Privacy Analytics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/data anonymisation/product/Privacy Analytics Inc
Average 90 stars, based on 1 article reviews
data anonymisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised and aggregated data on the management of patients with rheumatoid arthritis  (Lallemand inc)
90
Lallemand inc anonymised and aggregated data on the management of patients with rheumatoid arthritis
Annual average costs for biotherapy acquisition and care for a <t> rheumatoid arthritis </t> patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )
Anonymised And Aggregated Data On The Management Of Patients With Rheumatoid Arthritis, supplied by Lallemand inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised and aggregated data on the management of patients with rheumatoid arthritis/product/Lallemand inc
Average 90 stars, based on 1 article reviews
anonymised and aggregated data on the management of patients with rheumatoid arthritis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised accounting data  (Gallus BioPharmaceuticals)
90
Gallus BioPharmaceuticals anonymised accounting data
Annual average costs for biotherapy acquisition and care for a <t> rheumatoid arthritis </t> patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )
Anonymised Accounting Data, supplied by Gallus BioPharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised accounting data/product/Gallus BioPharmaceuticals
Average 90 stars, based on 1 article reviews
anonymised accounting data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised running data  (Strava Inc)
90
Strava Inc anonymised running data
Annual average costs for biotherapy acquisition and care for a <t> rheumatoid arthritis </t> patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )
Anonymised Running Data, supplied by Strava Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised running data/product/Strava Inc
Average 90 stars, based on 1 article reviews
anonymised running data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
genetic and health data anonymisation  (GeneYouIn Inc)
90
GeneYouIn Inc genetic and health data anonymisation
Annual average costs for biotherapy acquisition and care for a <t> rheumatoid arthritis </t> patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )
Genetic And Health Data Anonymisation, supplied by GeneYouIn Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genetic and health data anonymisation/product/GeneYouIn Inc
Average 90 stars, based on 1 article reviews
genetic and health data anonymisation - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier
anonymised images or data  (Perspectum Diagnostics Ltd)
90
Perspectum Diagnostics Ltd anonymised images or data
Annual average costs for biotherapy acquisition and care for a <t> rheumatoid arthritis </t> patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )
Anonymised Images Or Data, supplied by Perspectum Diagnostics Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anonymised images or data/product/Perspectum Diagnostics Ltd
Average 90 stars, based on 1 article reviews
anonymised images or data - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Annual average costs for biotherapy acquisition and care for a rheumatoid arthritis patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )

Journal: European Journal of Hospital Pharmacy. Science and Practice

Article Title: Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

doi: 10.1136/ejhpharm-2016-000904

Figure Lengend Snippet: Annual average costs for biotherapy acquisition and care for a rheumatoid arthritis patient with adalimumab, etanercept, originator infliximab or biosimilar infliximab: 2012 and 2015 calculated costs (data from the Alsace population 24 )

Article Snippet: The authors are grateful to Pascal Lallemand, Pascale Willem and Bérangère Pierre for extracting the 2012 anonymised and aggregated data on the management of patients with rheumatoid arthritis, and to Rama Piotto for proofreading and linguistic review of the manuscript.

Techniques:

Estimated annual budget savings attributable to the introduction of biosimilar infliximab for the treatment of adult rheumatoid arthritis patients, according to three different scenarios

Journal: European Journal of Hospital Pharmacy. Science and Practice

Article Title: Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

doi: 10.1136/ejhpharm-2016-000904

Figure Lengend Snippet: Estimated annual budget savings attributable to the introduction of biosimilar infliximab for the treatment of adult rheumatoid arthritis patients, according to three different scenarios

Article Snippet: The authors are grateful to Pascal Lallemand, Pascale Willem and Bérangère Pierre for extracting the 2012 anonymised and aggregated data on the management of patients with rheumatoid arthritis, and to Rama Piotto for proofreading and linguistic review of the manuscript.

Techniques:

Additional rheumatoid arthritis patients who could be treated for 1 year if the savings were spent on biosimilar infliximab

Journal: European Journal of Hospital Pharmacy. Science and Practice

Article Title: Biosimilar infliximab for the management of rheumatoid arthritis in France: what are the expected savings?

doi: 10.1136/ejhpharm-2016-000904

Figure Lengend Snippet: Additional rheumatoid arthritis patients who could be treated for 1 year if the savings were spent on biosimilar infliximab

Article Snippet: The authors are grateful to Pascal Lallemand, Pascale Willem and Bérangère Pierre for extracting the 2012 anonymised and aggregated data on the management of patients with rheumatoid arthritis, and to Rama Piotto for proofreading and linguistic review of the manuscript.

Techniques: